Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus

NCT01193218 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

547

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo (low dose)
DRUG: Placebo (low dose)
DRUG: Placebo (mid dose)
DRUG: Placebo (high dose)
DRUG: BI 10773
DRUG: Placebo (mid dose)
DRUG: Placebo (high dose)
DRUG: Placebo (high dose)
DRUG: BI 10773
DRUG: BI 10773
DRUG: Placebo (mid dose)
DRUG: Placebo (high dose)
DRUG: Placebo (low dose)
DRUG: Placebo (low dose)
DRUG: BI 10773
DRUG: Placebo (mid dose)

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]